This event features members of the Ogletree Deakins Workplace Safety and Health Practice Group, in-house counsel, and corporate safety directors from across the country.
Don’t miss Ogletree Deakins’ 2027 Workplace Strategies seminar, which will be held May 5-7, 2027. This annual seminar is the premier event of its kind for sophisticated human resources professionals, in-house counsel, and other business professionals.
The U.S. Department of Justice’s April 2026 order reclassifying certain marijuana products from Schedule I to Schedule III under the Controlled Substances Act marks a seismic shift in federal drug policy—and raises urgent questions for employers navigating workplace drug policies, disability accommodation requests under the ADA, and drug testing programs. The speaker will discuss the order’s key distinctions, including the divide between medical and non-medical use, the unsettled implications for DOT-regulated workforces, and the continued relevance of existing state law obligations. The speaker will also discuss the potential ADA-related claims and risks facing Alabama employers, particularly now that Alabama’s medical marijuana program is operational after years of delays following the law’s 2021 passage. Attendees will receive practical, business-focused guidance on how to audit their current drug policies and effectively position their organizations for this new landscape.
Ogletree Deakins’ Workplace Safety and Health Practice Group is proud to present its 7th annual California Workplace Safety Conference. This conference, designed for safety and HR professionals, general counsel, and risk managers, will equip you with the knowledge to confidently navigate the Cal/OSHA landscape.
Ogletree Deakins’ Workplace Safety and Health Practice Group is proud to present its 7th annual California Workplace Safety Conference. This conference, designed for safety and HR professionals, general counsel, and risk managers, will equip you with the knowledge to confidently navigate the Cal/OSHA landscape.